Ozempic Face: Causes, Prevention, and Treatment Options

"Ozempic face" is not a medical term but a colloquial description of facial changes that occur during significant weight loss on semaglutide (Ozempic/Wegovy) and similar GLP-1 medications. Key characteristics include:

• Hollowed cheeks and sunken appearance
• Increased visibility of wrinkles and fine lines
• Sagging skin around the jawline and neck
• Loss of under-eye volume, creating dark circles
• An overall aged or gaunt appearance

It's important to note that these changes aren't unique to semaglutide — they occur with any significant weight loss. However, the rapid pace of GLP-1-mediated weight loss can make facial changes more dramatic and noticeable.

The face contains specialized fat pads (malar, buccal, and periorbital) that provide structure and a youthful appearance. During weight loss, the body doesn't selectively burn only visceral or subcutaneous fat — facial fat is lost alongside body fat.

Key contributing factors:

• Rate of loss: Rapid weight loss (common with semaglutide) doesn't give skin time to retract, leading to sagging
• Age: Older individuals have less collagen and elastin, making skin less able to bounce back after volume loss
• Total weight lost: Greater total weight loss correlates with more pronounced facial changes
• Collagen loss: Caloric restriction can reduce collagen synthesis, compounding the aging effect
• Muscle loss: Facial muscles can atrophy during significant caloric deficits

Not everyone on semaglutide will develop noticeable facial changes. Higher risk factors include:

• Age over 40 (reduced skin elasticity)
• Losing more than 20% of body weight
• History of smoking (collagen damage)
• Sun damage (reduced skin resilience)
• Lower starting BMI (less facial fat to spare)
• Genetic predisposition to facial fat loss

During treatment:

• Lose weight at a moderate pace — consider slower dose titration
• Maintain adequate protein intake to preserve collagen and muscle
• Stay well-hydrated (dehydration worsens the gaunt appearance)
• Use SPF daily to protect remaining collagen
• Consider collagen peptide supplementation (10-15g daily)
• Facial exercises may help maintain some muscle tone

Peptide support: GHK-Cu is a copper peptide under investigation for its collagen-stimulating and skin-rejuvenating properties. Some researchers explore its potential to support skin elasticity during weight loss protocols.

After treatment: Dermal fillers (hyaluronic acid) can restore lost facial volume. Microneedling, radiofrequency treatments, and PRP therapy may improve skin quality and tightness.

For researchers studying semaglutide's effects on body composition and exploring supportive peptides like GHK-Cu, Ascension Peptides offers verified, third-party tested compounds with full certificates of analysis.